Glucommander eGlycemic Management System®
eGlycemic Management System (eGMS) is an EHR-integrated, cloud-based software solution that supports safe and effective glycemic management and insulin dosing.
eGMS offers personalized insulin dosing decision support at the point of care. Unlike paper protocols, sliding scale methods and digital insulin calculators, eGMS uses an evidence-based, FDA-cleared algorithm, Glucommander™. Glucommander leverages real-time and historical data to personalize insulin dosing by learning each patient’s insulin sensitivity and anticipating future need.
The result? Patients experiencing glycemic management challenges get into target range faster , stay within tighter parameters  and experience fewer insulin-related adverse drug events  than patients treated with other protocols.
In addition to dosing support, eGMS offers tools for doctors, nurses, pharmacists, CDCESs, hospital leadership and others to optimize insulin management. These tools include:
- Advanced glycemic management analytics
- Continuous surveillance of blood glucose levels across the entire patient population
- Dynamically adjusted timing for BG checks with automated reminders
- Dashboards to support coordination of care
Glucommander provides insulin dosing decision support and is FDA-cleared for use with adult and pediatric patients ages 2 and above. Glucommander is available in 3 different treatment modules that support patients and providers across the continuum of care.
Healthcare facilities can decide to implement one or more Glucommander treatment modules based on the units and care settings at their facilities:
Glucommander Treatment Modules
GlucoSurveillance, GlucoView, GlucoMetrics
Watch the Product Overview Video:
The glycemic management status quo is unsustainable.
Insulin dosing in the inpatient setting has remained largely unchanged for half a century. Simplified protocols seek to ease provider burden but can’t provide personalized care. Meanwhile, more complex protocols that are dependent on manual calculations are prone to dangerous errors.
What these status quo methodologies have in common is that they’re not safe and they’re not the standard of care.
Sliding scale and other one-size-fits-all protocols are outdated and dangerous, resulting in higher rates of hyperglycemia and hypoglycemia than Glytec’s personalized, algorithm- driven solution.  Reliance on protocols that don’t dynamically adjust based on patient needs is strongly discouraged by the American Diabetes Association. 
In addition, traditional paper protocols and most digital insulin dosing calculators provide no data for further analysis and lack safety guardrails to prevent errors in treatment.
Considered alongside the increasing prevalence of diabetes in the U.S.  and the outsized impact  patients with glycemic issues have on the healthcare system, reliance on the status quo is a recipe for disaster.
And it’s not just people with diabetes who require insulin in the hospital; stress hyperglycemia is often found with patients who are undergoing surgery or who are critically ill. These patients are often not given insulin therapy that has been proven to improve their outcomes because status quo methodologies don’t have a way of identifying them.
Glycemic management in the U.S.:
Glycemic management reimagined
Ineffective glycemic management has consequences that reach far beyond the patient bed, and stakeholders throughout the hospital have a role to play in ensuring the safe and effective treatment of patients with glycemic issues.
eGMS is a holistic solution for improving glycemic management throughout the healthcare system. Our cloud-based, EHR-integrated technology unites doctors, nurses, pharmacists, quality teams, hospital leadership and others around a common goal: better, safer care.
By equipping all stakeholders with the tools and data they need to make better decisions, eGMS has been repeatedly proven to enhance patient safety, improve quality of care and decrease costs compared to the status quo.
Real results from real hospitals:
Glucommander: Insulin dosing decision support
Our algorithm-driven insulin dosing software is the heart of eGMS. Glucommander is FDA-cleared and indicated for use in IV, SubQ and outpatient settings.
Glucommander: IV Workflow example
Glucommander includes an array of safety features to guide best practice insulin dosing methodology and improve patient safety and outcomes. These guardrails supplement clinicians’ decision-making by leveraging available data to draw their attention to potentially dangerous situations.
- Glucose velocity warning: Alerts nurses about sudden drops in patient blood glucose and prompts a BG recheck sooner to ensure that patients achieve target range safely. This feature is designed to prevent hypoglycemia and side effects like cerebral edema that are caused by rapid decrease in blood glucose.
- Anion gap analysis: Alerts nurses to high anion gaps to prevent premature discontinuation of treatment before resolution of DKA.
- Meter Max™ feature: Allows nurses to leverage the algorithm’s ability to recommend insulin doses when blood glucose values are above the glucose meter limit without waiting for lab values. Designed to prevent large drops in BG values so the patient achieves target range as soon as safely possible.
Integrations & Access
Accurate data is critical to calculating a personalized, safe and effective insulin dose. eGMS utilizes secure integrations with health systems’ EMRs to capture relevant data that already exists and to close the data loop with minimal data entry, which improves patient safety and reduces workflow friction for clinicians.
- SmartClick: Enables single sign-on and access to eGMS from within the EMR
- ADT: Imports patient information like demographics, height and weight
- Lab Results: Imports lab results like A1C, blood glucose and anion gap
- Order: Glucommander automatically receives initial parameters as ordered by the provider and displays this information when the nurse starts treatment
- Charting: Charts Glucommander data on the EMR flowsheet to display all patient care history in a single location without needing to double document
- Medication administration confirmation: Once a medication is charted on the MAR, the interface sends dose confirmation back to Glucommander to close the data loop without manual effort
GlucoView®: Glycemic status and alerts
eGMS includes a dashboard of glycemic status indicators for all patients in a unit, supporting team nursing and coordination of care (especially during shift changes).
GlucoView allows nursing teams to see Next BG Due for all patients in one view, so they can proactively plan and prioritize patient care.
GlucoSurveillance®: At-risk patient identification
eGMS interfaces with the hospital’s laboratory information system to continuously analyze the blood glucose values of all patients for whom data is available (not just those with Glucommander orders) to proactively identify patients with hyperglycemia.
The GlucoSurveillance dashboard notifies the designated clinician about patients with hyperglycemia who are at risk for adverse effects. Using GlucoSurveillance, providers can treat patients needing insulin therapy sooner, which improves patient safety.
GlucoSurveillance can be used by individual providers to monitor their patients, but is also a tool used by CDCES teams or designated clinical leads to identify and recommend treatment.
GlucoMetrics®: Glucose data analytics and reporting
GlucoMetrics and Glytec’s other reporting capabilities provide insights into organizational glycemic management performance by tracking KPIs like incidence of hyperglycemia and hypoglycemia, time to target blood glucose, best practice adherence data like percent of timely BG checks and utilization reports.
Measuring and tracking glycemic management performance is critical to long-term success. Glytec’s out of the box reporting enables hospital leadership, quality teams and providers to identify areas of opportunity in the current program, set actionable goals and track progress without needing to configure reports or manage spreadsheets.
eGMS includes a variety of ready-made reports, with the opportunity to drill down further by time period, patient history of diabetes, patient location, treatment type, renal status, BMI, diagnosis, admission glucose and other factors.
View glucose management KPIs from across the healthcare system in one location. Filters allow you to easily find and compare data.
View KPIs by facility and benchmark patients treated with Glucommander against those untreated, or treated with other protocols.
Measure healthcare worker adherence to best practices that ensures optimal results. The Blood Glucose Check Timeliness Report shows performance over time as well as a peer benchmark showing how well your facility is performing compared to other Glytec customers.
A proven process for change management
Glytec’s streamlined post-purchase process ensures all stakeholders have exactly what they need to achieve great results. Our cloud-based technology enables remote implementation and upgrades and reduces reliance on your technical resources to maintain the software.
Quick turnaround (as little as 12 weeks)
100% remote implementation and update capabilities
Standardized technical process to minimize IT lift and provide assistance and resources for implementation
Training modules and resources delivered via your own e-learning system
Unlimited 24/7/365 clinical and technical support
No additional cost for training and support
Implement in as little as 12 weeks.
eGMS is EMR agnostic - we’ve completed hundreds of implementations that integrate with Epic and Cerner, as well as many other EMR platforms. Our team can provide more details about integrating with your specific EMR during a consultation.
eGMS has been implemented at over 300 hospitals, including:
1. Comparative Effectiveness of a Computerized Algorithm Versus a Physician Instituted Protocol to Manage Insulin Infusions After Cardiac Surgery. Clinical Medicine & Research, Apr 2014.
2. Newsom R, Patty C, Camarena E, Gray T, Sawyer R, Brown B, McFarland R. Safely Converting From Sliding Scale to Basal Bolus Insulin Across an Entire Medical Center via Implementation of the eGlycemic Management System. American Diabetes Associa- tion Scientific Sessions. June 2017.
3. Dudley D, Gaines M. Use of Technology Reduces Incidence of Hypoglycemia-Related Adverse Drug Events Among Patients Re- quiring Insulin Therapy While Hospitalized. DTS Virtual Poster Meeting. June 18, 2020.
4. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020. American Diabetes Association. Diabetes Care Jan 2020, 43 (Supplement 1) S193-S202; DOI: 10.2337/dc20-S015
5. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2020. ttps://www.cdc.gov/diabetes/data/statistics/statistics-report.html
6. Economic Costs of Diabetes in the U.S. in 2017. American Diabetes Association. Diabetes Care 2018 Mar; dci180007. https://doi.org/10.2337/dci18-0007
7. Guillermo E. Umpierrez, Scott D. Isaacs, Niloofar Bazargan, Xiangdong You, Leonard M. Thaler, Abbas E. Kitabchi, Hyperglyce- mia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes, The Journal of Clinical Endocrinol- ogy & Metabolism, Volume 87, Issue 3, 1 March 2002, Pages 978–982, https://doi.org/10.1210/jcem.87.3.8341
8. Pennsylvania Patient Safety Authority. Focus on high-alert medications. Pa Patient Saf Advis. 2004;1(3):6. http://patientsafety.pa.gov/ADVISORIES/Pages/200409_06.aspx
9. Rabinovich, M., Grahl, J., Durr, E., Gayed, R., Chester, K., McFarland, R., & McLean, B. (2018). Risk of Hypoglycemia During Insulin Infusion Directed by Paper Protocol Versus Electronic Glycemic Management System in Critically Ill Patients at a Large Academ- ic Medical Center. Journal of Diabetes Science and Technology, 12(1), 47–52. https://doi.org/10.1177/1932296817747617
10. Mumpower A, Parsons T. Relationship Between Glycemic Control Using eGMS and Readmission Rates in Cardiovascular Patients Hospitalized with AMI, CHF or Undergoing CABG During the Implementation of a System Wide Glycemic Initiative. 1. 2016 Diabe- tes Technology Meeting Abstracts. Journal of Contemporary Ethnography. 2017;11(2):645-668. doi:10.1177/0891241606286997
11. Mabrey M, Clark J, Burks J, McFarland R, Hebblewhite H, Williams A. New Interfaces for eGlycemic Management System Saves Nursing Time and Improves Patient Outcomes: Time and Motion Nursing Study. Poster presented at: American Association of Clinical Endocrinologists Scientific & Clinical Congress; May 2014; Las Vegas, Nevada.